These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9523006)

  • 21. The proline-rich sequence of CD3epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes.
    Mingueneau M; Sansoni A; Grégoire C; Roncagalli R; Aguado E; Weiss A; Malissen M; Malissen B
    Nat Immunol; 2008 May; 9(5):522-32. PubMed ID: 18408722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery.
    Brown N; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):119-26. PubMed ID: 16122773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The level of CD4 surface protein influences T cell selection in the thymus.
    Frank GD; Parnes JR
    J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
    Bot A; Casares S; Bot S; von Boehmer H; Bona C
    J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
    Matuszyk J; Zioło E; Kobzdej M; Strzadala L
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor diversity prevents T-cell lymphoma development.
    Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
    Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymic lymphomas in interleukin 9 transgenic mice.
    Renauld JC; van der Lugt N; Vink A; van Roon M; Godfraind C; Warnier G; Merz H; Feller A; Berns A; Van Snick J
    Oncogene; 1994 May; 9(5):1327-32. PubMed ID: 8152793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice.
    Kretschmer C; Murphy C; Biesinger B; Beckers J; Fickenscher H; Kirchner T; Fleckenstein B; Rüther U
    Oncogene; 1996 Apr; 12(8):1609-16. PubMed ID: 8622880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.
    Santos J; González-Sánchez L; Villa-Morales M; Ors I; López-Nieva P; Vaquero C; González-Gugel E; Fernández-Navarro P; Roncero AM; Guenet JL; Montagutelli X; Fernández-Piqueras J
    Oncogene; 2010 Sep; 29(38):5265-73. PubMed ID: 20639904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of cell surface receptors and mitogen reactivity of individual spontaneous AKR lymphomas.
    Nell LJ; Richie ER
    Exp Hematol; 1981 Jul; 9(6):611-8. PubMed ID: 6973483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumorigenicity of T lymphoma/T lymphoma hybrids and T lymphoma/normal cell hybrids.
    Hays EF; Weinroth SE; MacLeod CL; Kitada S
    Int J Cancer; 1986 Oct; 38(4):597-601. PubMed ID: 3759264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BW5147 and Derivatives for the Study of T Cells and their Antigen Receptors.
    White J; O'Brien RL; Born WK
    Arch Immunol Ther Exp (Warsz); 2020 May; 68(3):15. PubMed ID: 32419056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the transgenic integration site in 2C T cell receptor transgenic mice.
    Son CY; Haines BB; Luch A; Ryu CJ
    Transgenic Res; 2018 Oct; 27(5):441-450. PubMed ID: 30132177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth regulation of a T-cell lymphoma via the T-cell receptor.
    O'Neill HC
    Leuk Res; 1994 Jan; 18(1):23-8. PubMed ID: 8289463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate.
    Hesterberg RS; Liu M; Elmarsafawi AG; Koomen JM; Welsh EA; Hesterberg SG; Ranatunga S; Yang C; Li W; Lawrence HR; Rodriguez PC; Berglund AE; Cleveland JL
    Cancer Immunol Res; 2022 Oct; 10(10):1263-1279. PubMed ID: 35969234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a human T-lymphoma cell line (H-TL90) and analysis of its biological characteristics.
    Shi L; Liu X; Zhang Y; Li X; Li D; Wang W
    Chin Med Sci J; 1995 Sep; 10(3):178-80. PubMed ID: 8580490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting TCR-repertoire diversity.
    Wedderburn LR; Bowness P
    Immunol Today; 1994 Jan; 15(1):41. PubMed ID: 8136012
    [No Abstract]   [Full Text] [Related]  

  • 40. Loss of T cell receptor diminished tumorigenicity of thymocyte-derived lymphoma cells in the T cell receptor transgenic mice.
    Kobzdej M; Matuszyk J; Zioło E; Strzadała L
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):307-13. PubMed ID: 9523006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.